A joint filing agreement was
Filed with the SEC on · accession 0000919574-26-005663
VJET filed a SCHEDULE 13G (schedule 13g) with the SEC on Aug 21, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -99.8% by the first close after the filing.
A joint filing agreement was filed under Schedule 13G by C/M Capital Master Fund LP, WVP Emerging Manager Onshore Fund LLC, C/M Capital Partners LP, Thomas Walsh, and Jonathan Juchno, indicating a group position in Catheter Precision, Inc. (VTAK).
Close before
$923.40
Mar 28, 2024
First close after
-99.84%
$1.52
5 trading days
-99.90%
$0.93
Since filing
-99.94%
$0.52
✦ Ask GOAX AI about this filing — what it means for VJET, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for VJET?
Click hereVJET filed a SCHEDULE 13G (SEC filing). A joint filing agreement was filed under Schedule 13G by C/M Capital Master Fund LP, WVP Emerging Manager Onshore Fund LLC, C/M Capital Partners LP, Thomas Walsh, and Jonathan Juchno, indicating a group position in Catheter Precision, Inc. (VTAK).
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
VJET closed at $923.40 before the filing and $1.52 on Oct 1, 2026 (-99.84%). Five trading days later: $0.93 (-99.90%).
Get alerts when VJET files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days